Cargando…

Dynamic changes in the regulatory T-cell heterogeneity and function by murine IL-2 mutein

The therapeutic expansion of Foxp3(+) regulatory T cells (Tregs) shows promise for treating autoimmune and inflammatory disorders. Yet, how this treatment affects the heterogeneity and function of Tregs is not clear. Using single-cell RNA-seq analysis, we characterized 31,908 Tregs from the mice tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Daniel R, Wu, Hao, Driver, Ian, Ingersoll, Sarah, Sohn, Sue, Wang, Songli, Li, Chi-Ming, Phee, Hyewon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156283/
https://www.ncbi.nlm.nih.gov/pubmed/32269069
http://dx.doi.org/10.26508/lsa.201900520
Descripción
Sumario:The therapeutic expansion of Foxp3(+) regulatory T cells (Tregs) shows promise for treating autoimmune and inflammatory disorders. Yet, how this treatment affects the heterogeneity and function of Tregs is not clear. Using single-cell RNA-seq analysis, we characterized 31,908 Tregs from the mice treated with a half-life extended mutant form of murine IL-2 (IL-2 mutein, IL-2M) that preferentially expanded Tregs, or mouse IgG Fc as a control. Cell clustering analysis revealed that IL-2M specifically expands multiple sub-states of Tregs with distinct expression profiles. TCR profiling with single-cell analysis uncovered Treg migration across tissues and transcriptional changes between clonally related Tregs after IL-2M treatment. Finally, we identified IL-2M–expanded Tnfrsf9(+)Il1rl1(+) Tregs with superior suppressive function, highlighting the potential of IL-2M to expand highly suppressive Foxp3(+) Tregs.